“Mammography screening has been promoted to the public with three simple promises that all appear to be wrong: It saves lives and breasts by catching the cancers early.”
“I believe that if screening had been a drug, it would have been withdrawn from the market long ago.”
~ Peter C Gøtzsche
With Breast Cancer Awareness Month just around the corner, a new study promises to undermine the multi-billion dollar cause-marketing orgy that shepherds millions of women into having their breasts scanned for cancer with x-rays that themselves are known to contribute to breast cancer.
If you have followed GreenMedInfo.com for any length of time, you know that we often report on the adverse effects of mammography, of which there are many. From the radiobiological and psychological risks of the procedure itself, to the tremendous harms of overdiagnosis and overtreatment, it is becoming clearer every day that those who subject themselves to screening as a “preventive measure” are actually putting themselves directly into harms way, unnecessarily.
Now, a study conducted by Peter C Gøtzsche, of the Nordic Cochrane Centre, published in the Journal of the Royal Society of Medicine and titled “Mammography screening is harmful and should be abandoned,” strikes to the heart of the matter by showing the actual effect of decades of screening has not been to reduce breast cancer specific mortality, despite the generation of millions of new so-called “early stage” or “stage zero” breast cancer diagnoses.
Previous investigation on the subject by Gotzsche resulted in the discovery that overdiagnosis occurs in a staggering 52% of patients offered organized mammography screening, which equates to “one in three breast cancers being overdiagnosed.” The problem with overdiagnosis is that it almost always goes unrecognized. This then results in overtreatment with aggressive interventions such as lumpectomy, mastectomy, chemotherapy and radiation; overtreatment is a euphemistic term that describes being severely harmed and/or having one’s life shortened by unnecessary medical treatment. Some of these treatments, such as chemotherapy and radiation, can actually enrich cancer stem cells within tumors, essentially altering cells from benign to malignant, or transforming already cancerous cells into far deadlier phenotypes.
Other recent research has determined that the past 30 years of breast cancer screening has lead to the overdiagnosis and overtreatment of about 1.3 million U.S. women, i.e. tumors were detected on screening that would never have led to clinical symptoms, and should never have been termed “cancers” in the first place. Truth be told, the physical and psychophysical suffering wrought by the harms of breast cancer screening can not even begin to be quantified.
Gøtzsche is very clear about the implications of his review on the decision to undergo mammography. He opines that the effect of screening on mortality, which is the only true measure of whether a medical intervention is worth undertaking, is to increase total mortality.
Gøtzsche summarizes his findings powerfully:
Mammography screening has been promoted to the public with three simple promises that all appear to be wrong: It saves lives and breasts by catching the cancers early. Screening does not seem to make the women live longer; it increases mastectomies; and cancers are not caught early, they are caught very late. They are also caught in too great numbers. There is so much overdiagnosis that the best thing a women can do to lower her risk of becoming a breast cancer patient is to avoid going to screening, which will lower her risk by one-third. We have written an information leaflet that exists in 16 languages on www.cochrane.dk, which we hope will make it easier for a woman to make an informed decision about whether or not to go to screening.
I believe that if screening had been a drug, it would have been withdrawn from the market long ago. Many drugs are withdrawn although they benefit many patients, when serious harms are reported in rather few patients. The situation with mammography screening is the opposite: Very few, if any, will benefit, whereas many will be harmed. I therefore believe it is appropriate that a nationally appointed body in Switzerland has now recommended that mammography screening should be stopped because it is harmful.
We are only a month away from Breast Cancer Awareness Month, a cause marketing orgy bedecked with pink ribbons, and infused with a pinkwashed mentality that has entirely removed the word “carcinogen,” i.e. the cause, from the discussion. All the better to raise billions more to find the “cure” everyone is told does not yet exist.
Women need to break free from the medical industrial complex’s ironclad hold on their bodies and minds, and take back control of their health through self-education and self-empowerment. The following articles and resources should help aid in that goal:
© October 20, 2016 GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for the newsletter here http://www.greenmedinfo.com/greenmed/newsletter.